Caissa Capital Management ltd. 4
4 · Avalo Therapeutics, Inc. · Filed May 22, 2023
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common stock
2023-05-18$3.29/sh+13,121$43,163→ 1,360,200 total(indirect: See Footnote (1)) - Purchase
Common stock
2023-05-22$3.34/sh+7,000$23,358→ 1,373,700 total(indirect: See Footnote (1)) - Purchase
Common stock
2023-05-19$3.52/sh+6,500$22,852→ 1,366,700 total(indirect: See Footnote (1))
Holdings
- 182,300
Common stock
Footnotes (5)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.80 to $3.40, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4 to $3.6, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00 to $3.72, inclusive.
- [F5]These share are directly owned by Mr. Golestaneh in his personal capacity.